Skip to main content

. 1984 Nov;37(11):1316–1317. doi: 10.1136/jcp.37.11.1316

Difficulties in the diagnosis of acquired immune deficiency syndrome.

E G Wilkins, C Roberts, W Taylor, R M Barnes

PMCID: PMC499015 PMID: 6334104

1316

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burt A. D., Scott G., Shiach C. R., Isles C. G. Acquired immunodeficiency syndrome in a patient with no known risk factors: a pathological study. J Clin Pathol. 1984 Apr;37(4):471–474. doi: 10.1136/jcp.37.4.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dylewski J., Chou S., Merigan T. C. Absence of detectable IgM antibody during cytomegalovirus disease in patients with AIDS. N Engl J Med. 1983 Aug 25;309(8):493–493. doi: 10.1056/NEJM198308253090813. [DOI] [PubMed] [Google Scholar]
Hughes W. T., McNabb P. C., Makres T. D., Feldman S. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1974 Mar;5(3):289–293. doi: 10.1128/aac.5.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
Luft B. J., Conley F., Remington J. S., Laverdiere M., Wagner K. F., Levine J. F., Craven P. C., Strandberg D. A., File T. M., Rice N. Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet. 1983 Apr 9;1(8328):781–784. doi: 10.1016/s0140-6736(83)91847-0. [DOI] [PubMed] [Google Scholar]
Oleske J. M. Effects of antimicrobials on host defence mechanism. J Antimicrob Chemother. 1984 May;13(5):413–415. doi: 10.1093/jac/13.5.413. [DOI] [PubMed] [Google Scholar]
Szychowska Z., Prandota-Schoepp A., Chabudzinska S. Rifampicin for Pneumocystic carinii pneumonia. Lancet. 1983 Apr 23;1(8330):935–935. doi: 10.1016/s0140-6736(83)91366-1. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES